Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 14, 2001

View Archived Issues

Licensing opportunity from NIH: BRCA1 mutants for modulating cellular response to DNA damage

Licensing opportunity from NIH: specific binding agents for KSHV vIL-6

Promising data reported for Visudyne in occult AMD and pathological myopia

IL-1ra protects cortical neurons following transient middle cerebral artery occlusion

Inhale Therapeutic Systems makes significant progress during 2000

American Biogenetic Sciences highlights 2000 progress, provides outlook for 2001

Independent cardiovascular study with Dusa's Levulan begins

Adjunctive treatment with Cerebrolysin associated with neuroprotection in acute ischemic stroke

Effects of BMP-7 in rats with transient MCA occlusion discussed at this week's stroke conference

Inflazyme reports company update

Potent PPAR agonists and their use presented by Merck & Co.

AstraZeneca dedicates resources to discovery of safe neuroprotective compounds

Novel imidazolines only stimulate insulin release during hyperglycemia

Thrombin inhibitors with high selectivity designed at ADIR

Mochida describes new series with potent cholesterol-lowering effects

Pierre Fabre reports imidazolines structurally related to idazoxan and potential uses

Patent issued to Welfide covers new IL-4/IL-5 production inhibitors

Discovery of prostate cancer gene detailed by Myriad

Involvement of MAPK, therapeutic role for MAPK inhibitors in cerebral vasospasm

Draxis Health cleared to begin phase II trials with AMI diagnostic in U.S. and Canada

Genta's Genasense enters phase III evaluation for multiple myeloma

Significant neuroprotective effects demonstrated for kappa opioid agonist

Theratechnologies commences phase II trials in sleep disorders

Dyax and Debiopharm move cystic fibrosis treatment into phase II

Beneficial effects of long-term glucosamine sulfate on osteoarthritis progression

Ilex Oncology acquires Symphar; Symphar becomes Ilex Research-Europe

Potential new agent for reducing NIDDM-associated hyperglycemia without side effects

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...